NCT03484546

Brief Summary

This study evaluates the optimum day of menstrual period for the excision of endometriomas to minimize the damage of surgery to normal ovarian tissue. Patients will be grouped as follicular, ovulatory and luteal according to menstrual days. Ovarian damage will be evaluated with both pathologic examination and anti-mullerian hormone levels before and after the surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

March 26, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 2, 2018

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

October 24, 2023

Status Verified

October 1, 2023

Enrollment Period

3.5 years

First QC Date

March 26, 2018

Last Update Submit

October 21, 2023

Conditions

Keywords

ovarian reserveendometriosisendometrioma

Outcome Measures

Primary Outcomes (2)

  • Determination of ovarian follicle damage via histological examination

    Histologic evaluation of the cystectomy excision material for health ovarian follicles

    5 days after the surgery

  • Change of anti-mullerian hormone level 6 months after surgery

    Comparison of pre-operative and 6 months after surgery of anti-mullerian hormone levels

    6 months

Study Arms (3)

folicular

Women who will undergo endometrioma cystectomy in her follicular phase of menstrual period.

Procedure: laparoscopic endometrioma cyst excision

ovulatory

Women who will undergo endometrioma cystectomy in her ovulatory phase (12-14th day of mestrual period cycle for women regular period) of menstrual cycle.

Procedure: laparoscopic endometrioma cyst excision

luteal

Women who will undergo endometrioma cystectomy in her luteal phase of menstrual period.

Procedure: laparoscopic endometrioma cyst excision

Interventions

laparoscopic resection of ovarian endometrioma

folicularlutealovulatory

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women who admitted to out-patient clinic between the ages of 18-40 years,had 4-10cm ovarian unilateral endometrioma and had an indication of laparoscopic ovarian endometrioma excision.

You may qualify if:

  • to 10 cm unilateral ovarian endometrioma
  • having clinically indication of laparoscopic ovarian endometrioma excision

You may not qualify if:

  • prior gynecologic surgery
  • prior abdominal surgery
  • additional operation in the same session
  • having the diagnosis of premature ovarian failure or ovarian insufficiency
  • having any diagnosis of malignancy
  • having diagnosis of a non-gynecologic chronicle disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Acibadem Fulya Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

Acibadem MAA University Atakent Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

Acibadem MAA University Maslak Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

Related Publications (1)

  • Takmaz O, Asoglu MR, Ceyhan M, Unsal G, Gungor M. Comparing ovarian reserve parameters after laparoscopic endometrioma resection in the follicular vs. luteal phase: a prospective cohort study. Front Med (Lausanne). 2024 Oct 15;11:1469858. doi: 10.3389/fmed.2024.1469858. eCollection 2024.

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood sample

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Ozguc Takmaz

    Acibadem MAA University Maslak Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 26, 2018

First Posted

April 2, 2018

Study Start

March 26, 2018

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

October 24, 2023

Record last verified: 2023-10

Locations